Indomethacin treatment slows disease progression and enhances a Th1 response in susceptible BALB/c mice infected with Leishmania major
about
The site of the bite: Leishmania interaction with macrophages, neutrophils and the extracellular matrix in the dermisThe immunomodulatory factors of bloodfeeding arthropod saliva.Clinical and experimental advances in treatment of visceral leishmaniasis.Malnutrition alters the innate immune response and increases early visceralization following Leishmania donovani infection.Combined treatment with interleukin-12 and indomethacin promotes increased resistance in BALB/c mice with established Leishmania major infectionsDual effect of Lutzomyia longipalpis saliva on Leishmania braziliensis infection is mediated by distinct saliva-induced cellular recruitment into BALB/c mice earProduction of eicosanoids and other oxylipins by pathogenic eukaryotic microbes.Phlebotomine salivas inhibit immune inflammation-induced neutrophil migration via an autocrine DC-derived PGE2/IL-10 sequential pathwayNucleosides present on phlebotomine saliva induce immunossuppression and promote the infection establishment.Nucleosides from Phlebotomus papatasi salivary gland ameliorate murine collagen-induced arthritis by impairing dendritic cell functions.The immunomodulatory factors of arthropod saliva and the potential for these factors to serve as vaccine targets to prevent pathogen transmission.Comparison of the effects of Leishmania major or Leishmania donovani infection on macrophage gene expression.In vitro indomethacin administration upregulates interleukin-12 production and polarizes the immune response towards a Th1 type in susceptible BALB/c mice infected with Leishmania mexicana.The modulatory effects of prostaglandin-E on cytokine production by human peripheral blood mononuclear cells are independent of the prostaglandin subtype.Effect of varying types of anti-arthritic drugs on Th1 and Th2 immune responses in mice.
P2860
Q26752781-C84D1266-CBEC-4E2C-963E-D9185A457FC6Q33962295-F339D94A-6CF5-475B-8680-AC8DA246B9B4Q33982648-91B2BEF9-804E-4696-A4F2-CFE4528E2D13Q34008436-77BC7E07-2A4E-4A0E-B282-E6840351036EQ34132796-3E929966-C2C6-45CF-98B1-ADB4EA290CEDQ34711299-19735D8D-8BC8-49DA-8FCD-F4CF1AF674C7Q35139747-DA0861A6-D24E-4837-89C5-16EB0E0E3A64Q35227682-F19869BA-1CA6-407E-81E3-CC5F7E49A60DQ35300310-0DC5C501-60AE-4474-8E26-1FE4EBD7B9E5Q35368022-FB4B95E1-4821-433B-A85C-E2F6AE7F7325Q36423181-11CCAC14-84B7-406B-B7B6-42DF4F944ABDQ36483603-702173EA-4880-499D-9AA6-C63489651F88Q43796056-D2A2939A-C6FE-4E1E-AEDD-04298A20AFE2Q44133286-3CBEBAC5-76AA-4F93-B0B9-4CD684D96BBBQ45255498-299E033A-2FC2-4F3D-B46B-C77C17C8EF77
P2860
Indomethacin treatment slows disease progression and enhances a Th1 response in susceptible BALB/c mice infected with Leishmania major
description
1999 nî lūn-bûn
@nan
1999 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Indomethacin treatment slows d ...... infected with Leishmania major
@ast
Indomethacin treatment slows d ...... infected with Leishmania major
@en
Indomethacin treatment slows d ...... infected with Leishmania major
@nl
type
label
Indomethacin treatment slows d ...... infected with Leishmania major
@ast
Indomethacin treatment slows d ...... infected with Leishmania major
@en
Indomethacin treatment slows d ...... infected with Leishmania major
@nl
prefLabel
Indomethacin treatment slows d ...... infected with Leishmania major
@ast
Indomethacin treatment slows d ...... infected with Leishmania major
@en
Indomethacin treatment slows d ...... infected with Leishmania major
@nl
P2093
P2860
P3181
P1433
P1476
Indomethacin treatment slows d ...... infected with Leishmania major
@en
P2093
J A Bleyenberg
L A De Freitas
P2860
P3181
P356
10.1046/J.1365-3024.1999.00211.X
P407
P577
1999-05-01T00:00:00Z